Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline

FHS
July 25, 2023
9:18 am

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its relentless commitment to providing laboratories of all sizes with individualized and tailored support to meet the evolving list of regional and global compliance requirements.

Trajectory of fear of cancer recurrence levels six to 18 months post-breast cancer diagnosis

Researchers examined the predictors of fear of cancer recurrence (FCR) and its trajectory among breast cancer (BC) patients.

September 19, 2023

TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T cell therapy program, for the treatment of AD

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced they are

February 13, 2025

After Delay, U.S. News Sets Tentative Timing for Med School Rankings Release

After being delayed for the second year in a row, a new — yet tentative — timeline was announced for this year’s “Best Medical Schools”

June 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.